Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, and National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Bethesda, Maryland.
Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, Maryland.
J Neuroendocrinol. 2019 Jul;31(7):e12663. doi: 10.1111/jne.12663. Epub 2019 Jan 16.
Ghrelin is a gastric hormone that has been implicated in the neurobiology of alcohol drinking. We have recently developed a ghrelin receptor (growth hormone secretagogue receptor; GHSR) knockout (KO) rat model, which exhibits reduced food consumption and body weight. In addition, recent preliminary work suggests that the gut-microbiome, which appears to interact with the ghrelin system, may modulate alcohol drinking. In the present study, we investigated the effects of GHSR deletion on alcohol consumption utilising GHSR KO and wild-type (WT) rats in three separate alcohol consumption paradigms: (i) operant self-administration (30-minute sessions); (ii) drinking in the dark (DID) (4-hour sessions); and (iii) intermittent access (24-hour sessions). These paradigms model varying degrees of alcohol consumption. Furthermore, we aimed to investigate the gut-microbiome composition of GHSR KO and WT rats before and after alcohol exposure. We found that the GHSR KO rats self-administered significantly less alcohol compared to WT rats in the operant paradigm, and consumed less alcohol than WT in the initial stages of the DID paradigm. No genotype differences were found in the intermittent access test. In addition, we found a significant decrease in gut-microbial diversity after alcohol exposure in both genotypes. Thus, the present results indicate that the ghrelin system may be involved in drinking patterns that result in presumably increased alcohol exposure levels. Furthermore, GHSR may constitute a potential pharmacological target for the reduction of binge-alcohol consumption. The potential functional role of the gut-microbiome in alcohol drinking, as well as interaction with the ghrelin system, is an interesting topic for further investigation.
胃饥饿素是一种胃激素,它与酒精摄入的神经生物学有关。我们最近开发了一种胃饥饿素受体(生长激素促分泌素受体;GHSR)敲除(KO)大鼠模型,该模型表现出食物摄入量和体重减少。此外,最近的初步研究表明,肠道微生物群似乎与胃饥饿素系统相互作用,可能调节酒精摄入。在本研究中,我们利用 GHSR KO 和野生型(WT)大鼠在三种不同的酒精消耗范式中研究了 GHSR 缺失对酒精消耗的影响:(i)操作性自我给药(30 分钟);(ii)暗饮(DID)(4 小时);和(iii)间歇访问(24 小时)。这些范式模拟了不同程度的酒精消耗。此外,我们旨在研究 GHSR KO 和 WT 大鼠在酒精暴露前后的肠道微生物群组成。我们发现,在操作性范式中,GHSR KO 大鼠自我给药的酒精量明显少于 WT 大鼠,并且在 DID 范式的初始阶段消耗的酒精量少于 WT 大鼠。在间歇访问测试中没有发现基因型差异。此外,我们发现两种基因型的肠道微生物多样性在酒精暴露后都显著下降。因此,目前的结果表明,胃饥饿素系统可能参与导致酒精暴露水平升高的饮酒模式。此外,GHSR 可能是减少 binge 饮酒的潜在药理学靶点。肠道微生物群在酒精摄入中的潜在功能作用以及与胃饥饿素系统的相互作用是进一步研究的一个有趣课题。